Company Filing History:
17 out of 1,210 
2 out of 2,968 
2 out of 2,893 
Years Active: 2013-2024
Title: **Innovative Contributions of Inventor Sara Jean Buhrlage**
Introduction
Sara Jean Buhrlage, an accomplished inventor based in Somerville, MA, has made significant strides in the field of oncology. With a total of 18 patents to her name, she has demonstrated an exceptional ability to innovate and contribute to cancer treatment. Her work focuses primarily on developing methods for treating lymphoplasmacytic lymphoma and other related B cell neoplasms.
Latest Patents
Among her latest patents, one notable invention is centered around methods to treat lymphoplasmacytic lymphoma. This invention provides compounds represented by various formulas (A, I-11, II, and V), specifically targeting Waldenström's macroglobulinemia and other B cell neoplasms. The methods involve administering effective amounts of these compounds to subjects in need, also exploring combinations with inhibitors of Bruton's tyrosine kinase (BTK) and other associated kinases.
Another significant patent involves USP7 inhibitors for treating multiple myeloma. This disclosure highlights the inhibitors' potential in treating cancers and other diseases mediated by USP7, offering promising avenues for future cancer therapies.
Career Highlights
Sara Jean Buhrlage has had a distinguished career, gaining experience at prominent institutions such as the Dana-Farber Cancer Institute and Harvard College. Her innovative research and dedication to cancer treatment have solidified her reputation within the scientific community.
Collaborations
Throughout her career, Sara has collaborated with notable professionals, including Nathanael Schiander Gray and Steven P Treon. These collaborations have provided her with a platform to expand her research and contribute to groundbreaking discoveries in cancer therapeutics.
Conclusion
Sara Jean Buhrlage’s contributions to the field of oncology through her numerous patents reflect her dedication to innovating cancer treatments. Her work continues to impact the lives of those affected by B cell neoplasms, showcasing her as a leading figure among inventors in the medical research sector.